Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-17 Isett Thomas Francis 3rd CEO and Executive Co-Chairman Option exercise · Series B Warrants (Right to Buy) +78,024 $1,000.00 $78.0M 1,275,000
2020-03-12 Isett Thomas Francis 3rd CEO and Executive Chairman Grant or award · Stock Option (right to buy) +975,000 $1.43 $1.4M 1,275,000
2020-02-20 Isett Thomas Francis 3rd CEO and Executive Chairman Other acquisition +121,976 1,275,000
2020-02-20 Isett Thomas Francis 3rd CEO and Executive Chairman Other disposition · Series A Warrants (Right to Buy) −100,000 $1,000.00 $100.0M 1,275,000
2020-02-20 Isett Thomas Francis 3rd CEO and Executive Chairman Other disposition · Series B Warrants (Right to Buy) −21,976 $1,000.00 $22.0M 1,275,000
2019-03-14 DART KENNETH BRYAN 10% owner Other acquisition +1 1

Page 7 of 7 · 126 trades